Wall Street’s Bold Bet: This Cryptocurrency Could Skyrocket 542% by 2028, Says Analyst Geoff Kendrick

Forget modest gains—one Wall Street analyst sees explosive growth ahead for a single digital asset.

The Bull Case

Geoff Kendrick's projection isn't for the faint-hearted. His 542% surge prediction by 2028 would make traditional stock returns look like pocket change. The cryptocurrency in question—while unnamed in the original data—clearly has analysts buzzing about its potential to disrupt conventional investment strategies.

Timing the Market

Kendrick's specific timeframe suggests he sees catalysts building over the next three years. Unlike traditional finance's gradual climbs, crypto markets can deliver life-changing returns in compressed timeframes—when you pick the right horse.

The Analyst's Track Record

Wall Street crypto predictions often miss the mark, but when they hit, they redefine portfolios. Kendrick's putting his reputation behind this call, betting that mainstream adoption and technological advances will fuel this particular asset's ascent.

Because nothing says 'sound investment' like betting your retirement on internet money that could either moon or crash based on a single tweet.

Image source: Getty Images.

1. Opendoor Technologies

(OPEN 3.00%) is a fairly young company, having gone public only in 2020. It's been growing rapidly, with an average annual growth rate of nearly 43% over the past three years -- and an amazing 293% increase over the past year.

What does Opendoor do? Well, it has what some suggest is a "risky business model." It helps people buy and sell homes via its online platform -- and it even buys homes from sellers to sell to buyers. With interest rates expected to drop over the coming year or longer, that can boost the company's business -- as lower rates mean home buying is easier for buyers. (Lower rates are typically good news for stocks, too, as it means companies can more easily borrow money with which to grow.)

If you're bullish on the real estate market and expect a lot of activity in it in the coming years, Opendoor Technologies could be a good fit for your portfolio. It even seems appealingly valued at recent levels, with a price-to-sales ratio of just 1.

If the company interests you, read up on its risks and opportunities. (For example, it may be laying off most of its employees.)

2. Broadcom

(AVGO 0.03%) is not only a semiconductor company, but also a software company -- and a leader in networking equipment. The proliferation of artificial intelligence (AI) technology is serving as a great tailwind for the company, as it requires chips and software.

Broadcom is cranking out AI chips, and its AI division is growing more briskly than that of-- which is impressive. It offers customizable AI accelerators for data centers, and data centers are proliferating, too, as they're needed to support AI activities.

Broadcom is also a dividend payer. Its recent dividend yield of 0.7% looks puny, but its rate of growth matters, too, and that has been strong, averaging 13% annually over the past five years. Its shares don't look bargain-priced, though, with a recent forward-looking price-to-earnings (P/E) ratio of 38, about twice its five-year average. Still, you might buy into the stock over time, or just add it to your watch list. If demand for Broadcom's chips and software grows rapidly, today's price might end up having seemed reasonable.

3. Intuitive Surgical

(ISRG 2.83%) Intuitive Surgical is a leader in robotic surgery equipment. It has more than 9,900 of its million-dollar-plus da Vinci robotic surgery systems installed in 72 countries. Together, they've been used to perform more than 16 million procedures.

The company has been growing briskly -- second-quarter revenue was up 21% year over year -- but some worry about the effect of tariffs, should they continue. Management is still projecting double-digit growth, in spite of them. A particularly appealing aspect of the business is that it generates 84% of its revenue not from the costly systems themselves, but from dependable recurring sales of servicing, supplies, and accessories for the machines. Moreover, once a hospital has committed to a da Vinci machine, it can't go elsewhere for servicing and supplies.

Intuitive Surgical's stock trades at this writing with a forward P/E of 47, which is a bit below its five-year average of 56. Both those numbers are on the steep side, though, suggesting it may be overvalued, but know that the stock is priced more attractively lately than it usually has been.

So give these growth stocks some consideration. And remember that while growth stocks can grow much faster than the overall market, plenty of them are overvalued and some will flame out. So to mitigate that risk, we recommend investing in at least 25 companies and aiming to hold for at least five years.